To dissociate the possible differential effects of negative energy balance and reduction in body fat mass (FM) on inflammatory markers: C-reactive protein (CRP), fibrinogen, interleukin-6 (IL-6), haptoglobin, transferrin and the adipokines leptin and adiponectin. Methods: Thirty-three obese subjects (BMI: 34.0±3.1 kg/m 2 , age: 43.0±10.5 years, mean±s.d., 16 men) participated in a 20-week controlled dietary intervention divided into four periods. Weight reduction was induced by an 8-week low energy diet (3.4 MJ d À1 ) (LED-1) followed by a 4-week weight maintenance program (M-1). Subsequently participants underwent an additional 4-week LED (4.2 MJ d À1 ) (LED-2) followed by a final 4-week weight maintenance diet (M-2). Blood samples and anthropometrics were assessed at baseline and after LED-1, M-1, LED-2 and M-2. Results: Body weight was significantly reduced by 13% (13.7 ± 4.0 kg, Po0.0001) after LED-1. However, a reduction in highsensitive CRP (hs-CRP) by 35% (À1.1 (95% CI: À2.5:0.2) mg l À1 , P ¼ 0.02) only became apparent after LED-2, which produced an additional weight loss of 2.9 kg compared to baseline, and it was maintained after M-2 (À1.0 (À1.4:0.4) mg l À1 , P ¼ 0.02). Also IL-6 was reduced by 21% (À0.6 (À2.4:0.2) ng l À1 , P ¼ 0.02) after M-2. The reductions in hs-CRP and IL-6 were both associated with reduction in FM but not body weight. Haptoglobin, transferrin and leptin were significantly reduced after both LED-1 and LED-2, but increased during weight maintenance. Adiponectin was not significantly changed during the intervention. Conclusions: The results suggest that, whereas haptoglobin and transferrin respond more rapidly and are more susceptible to the acute change in energy balance, a reduction in hs-CRP and IL-6 seems to be achieved by a reduction in FM when a new steady state has been established.
Introduction
Obesity is a major health problem as it is an independent risk factor in the development of atherosclerosis, hypertension, hyperlipidemia and insulin resistance syndrome. [1] [2] [3] Epidemiological studies have associated elevated levels of acute phase proteins, mainly C-reactive protein (CRP), with cardiovascular diseases (CVD) and cardiac death. [4] [5] [6] [7] [8] Levels of several cytokines and acute phase proteins such as CRP, haptoglobin and fibrinogen, have been found to be adversely influenced by elevated body fat and to increase the risk of type 2 diabetes and coronary artery disease. [9] [10] [11] [12] The link between low-grade inflammation and risk of CVD is thought to be mediated by the elevated body fat mass (FM), as the adipocytes synthesize and secrete various cytokines, which stimulate the synthesis of acute phase reactants in hepatocytes. The pro-inflammatory cytokine interleukin-6 (IL-6) is a main stimulator of the production of most acute phase proteins, whereas other cytokines stimulate subgroups of acute phase proteins. With normal liver function the level of non-specific acute phase proteins such as CRP can increase up to 1000-fold during inflammation. 12 In patients with atherosclerosis the CRP level is chronically increased. Highsensitive CRP (hs-CRP) kits are used to detect small amounts of CRP in the blood, whereas normal CRP tests are unable to detect differences in the low-grade inflammation state.
Several studies have indicated that plasma hs-CRP is a strong independent predictor of future atherothrombotic events among individuals without known CVD. 13 The exact mechanisms relating obesity to inflammation are not clear. However, it is well established that a rapid weight loss reduces the concentration of cytokines, such as IL-6 and IL-18, that it increases adiponectin levels in obese subjects and that these changes are related with increased insulin sensitivity. [14] [15] [16] [17] A marked weight loss has also been found to reduce the concentration of acute phase proteins such as CRP and fibrinogen. [16] [17] [18] [19] However, only CRP has been connected to improvement in insulin resistance. 16 Several pro-inflammatory markers, including CRP and IL-6, have been linked to thrombotic cardiovascular events. 20, 21 However, the role of pro-inflammatory markers is uncertain. It is still unclear whether the increased level of pro-inflammatory molecules are biomarkers of the progression of CVD or whether they are actors involved in the pathogenesis of CVD. 18 There is some evidence to suggest that the latter is the case as the anti-inflammatory agent aspirin has been observed to reduce CRP and the risk of myocardial infarction. 8 To our knowledge no studies have investigated the effect of repeated weight reductions and a subsequent maintenance of body weight on the level of low-grade inflammatory markers. Weight loss will normally induce an immediate decrease in plasma leptin, LDL-cholesterol, glucose and insulin. Subsequent weight maintenance seems to either sustain the attained concentrations or to increase the levels towards baseline values. [22] [23] [24] This could indicate that the risk markers are influenced by both energy balance and changes in FM. The purpose of the present intervention was to disentangle the effect of weight loss, from steady-state to weight reduction, on the concentration of hs-CRP and other low grade pro-or anti-inflammatory markers like IL-6, fibrinogen, haptoglobin, transferrin, adiponectin and leptin in 33 overweight or obese subjects. The chosen markers have all previously been observed to be affected by obesity and/or weight loss, but have been investigated in a very different manner. 9, 10, [25] [26] [27] [28] [29] [30] Therefore, we also compared the changes in the well-investigated markers, hs-CRP and IL-6, with the mentioned acute phase reactants as an effect of weight loss regimens and maintenance. Furthermore, we attempted to compare hs-CRP and IL-6 with more traditional risk markers of the insulin resistance syndrome (IRS) and CVD.
Methods
Participants Forty-one participants (20 men, 21 women) were included in the study. Subjects were between 24 and 62 years, healthy, non-athletic, weight stable (o±3 kg in last 2 months) but overweight or obese (BMI: 28-40 kg/m 2 ). They had no frequent use of medication, systolic blood pressure o165 mm Hg and diastolic blood pressure o95 mm Hg and no evidence of metabolic or systemic diseases other than obesity. All subjects gave their written consent after having received verbal and written information about the study. The Municipal Ethical Committee of Copenhagen and Frederiksberg approved the study as being in accordance with the Helsinki II Declaration.
Five participants left the study within the first 4 weeks due to illness (n ¼ 1) or inability to follow the study protocol (n ¼ 4 continued in the study. Three participants left the study before completion due to inability to follow the study protocol (n ¼ 2) or pregnancy (n ¼ 1).
Study design
The present study was designed as a 20-week controlled intervention, divided into four periods. Weight reduction was induced with a low energy diet (LED) of 3.4 MJ d À1 in the first 8 weeks of the intervention (LED-1). All participants reduced their body weight with more than 8% and continued in a subsequent 4-week weight maintenance program (M-1). This was followed by a 4-week LED of 4.2 MJ d À1 (LED-2), which was in turn followed by a 4-week weight maintenance diet (M-2). Blood samples were drawn, and anthropometrical measures, heart rate, blood pressure and electrocardiogram were assessed on the day of the initiation of each intervention period, or a maximum of 4 days before, that is, at baseline and after 8 (LED-1), 12 (M-1), 16 (LED-2) and 20 (M-2) weeks.
Weight reduction and maintenance programs During the 8-week LED period all subjects followed a weight reduction program based on a strictly controlled 3.4 MJ d À1 low calorie formula diet (Speasy, Dansk Droge A/S, Ishøj, Denmark) consisting of six meals of 37 g formula suspended in 250 ml water. The diet provided 75 g protein (7 g caseinate, 68 g soy protein), 96 g carbohydrate (16 g maltodextrin, 80 g fructose), 15 g oat fibers and 12 g unsaturated fat per day. The last 4-week weight reduction (LED-2) period was based on the same LED diet but supplemented with 750 kJ d À1 of free-choice food items. To ensure compliance with the restricted extra calorie intake the subjects were instructed in an educational system described elsewhere. 31 The weight maintenance program was based on the same educational system. The subjects were instructed to consume energy intake in accordance with requirements in a weight maintenance diet. The subjects were instructed to abstain from alcohol in both the weight loss and the weight maintenance programs. To optimize compliance the participants consulted a dietician every second week. The consultations included both nutritional education and weighing. Apart from the weighing we did not control for compliance.
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Measurements of anthropometrics
All measurements were taken under the same standardized conditions. The participants were instructed to fast 12 h before the measurement except for 1 2 l of water. The subjects abstained from medication and alcohol for 24 h and from hard physical activity for 36 h before each measurement. To limit diurnal variation and inter-and intra-subject variations, all measurements were carried out according to an identical time schedule.
Body weight was measured to the nearest 0.05 kg on a decimal scale (Lindeltronic 8000, Copenhagen, Denmark), height to the nearest 0.5 cm and circumference of waist to the nearest 1 cm. Body composition, fat-free mass and FM were estimated by bioelectrical impedance analysis using an Animeter (Quadscan 4000, Bodystat Ltd, Douglas, Britain).
Heart rate and blood pressure were measured using an automatically inflating cuff (digital blood pressure meter model UA-743, A&D Company Ltd, Tokyo, Japan).
Measurement of blood parameters
All blood samples were taken under the same standardized conditions described above. The blood samples were drawn from an antecubital vein after minimum 10 min of resting in a supine position. Samples were processed within 1 hour after collection, divided into cryo-tubes and stored at À80 1C for later analysis.
Frozen specimens of serum and plasma were thawed at room temperature before analysis. Serum samples were analyzed for hs-C-reactive protein (mg l
À1
, ABX Diagnostic Latex CRP kit, ABX Diagnostics, Montpellier, France, interassay variation (CV inter ): 2.9% and intra-assay variation (CV intra ): 1.0%), transferrin (mmol l
, TRSF-2, Roche Diagnostics GmbH, Mannheim, Germany, CV inter : 1.8% and CV intra : 1.9%), haptoglobin (mmol l
, HAPT-2, Roche Diagnostics GmbH, CV inter : 1.8% and CV intra : 0.9%), interleukin-6 (ng l À1 , Quantikine HS600, R&D Systems, Minneapolis, MN, USA, CV inter : 8.2% and CV intra : 5.4%), insulin (pmol l À1 , Insulin kit B080-101, Wallac Oy, Turku, Finland, CV inter : 7.1% and CV intra : 3.5%), glucose (mmol l
, Gluco-quant Glucose/HK, Roche Diagnostics GmbH, CV inter : 1.6% and CV intra : 0.9%), leptin (ng ml À1 , Human leptin RIA kit, DRG Instruments GmbH, Marburg, Germany, CV inter : 5.6% and CV intra : 4.4%), triglycerides (mmol l
, Triglycerides GPO-PAP, Roche Diagnostics GmbH, CV inter : 3.6% and CV intra : 1.5%), total cholesterol (mmol l
, CHOD-PAP, Roche Diagnostics GmbH, CV inter : 1.5% and CV intra :
, HDL-C þ , Roche Diagnostics GmbH, CV inter : 3.0% and CV intra : 1.8%).
Plasma samples were analyzed for fibrinogen (g l À1 , Diagnostica STAGO, Francoville, France, CV inter : 4.1% and CV intra : 3.9%), adiponectin concentrations in duplets (mg l À1 , Human Adiponectin RIA Kit (HADP-61 K), LINCO Research Inc., St Charles, MO, USA, CV inter : 6.9-9.3% and CV intra : 1.8-6.2%). Serum/plasma samples from each individual subject were analyzed continually in a single batch to eliminate assay variation. Homeostasis model assessment for insulin resistance (HOMA IR) was estimated as previously described by Haffner et al. 32 The concentration of low-density lipoprotein (LDL) cholesterol was estimated after Friedwald et al.
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Statistical analysis All descriptive data are given in mean and s.d. All results are given in mean and s.e., or 95% confidence interval (95% CI). The significant level was set at o0.05. Statistical analyses were performed with SAS 8.2 (SAS Institute, Cary, NC, USA). All data were analyzed on completers only (n ¼ 33). In this study, no blood samples were drawn from subjects with evidence of an active infection, systemic inflammatory processes or trauma. However, hs-CRP values above 10 mg l À1 were excluded as they could be spuriously high due to an intercurrent infection. 34 At baseline three samples were omitted due to high hs-CRP level, two samples after LED-1, two samples after M-1, two samples after LED-2 and one sample at study completion. One subject was omitted from the hs-CRP data set (all five assessment periods) due to hs-CRP levels above 10 mg l
À1
. Mixed model analysis of covariance was used to test differences between periods and baseline values. All measurements, including baseline values, were included as dependent variables, periods and gender were included as independent fixed variables, age was included as a covariate and participants were included as an independent random variable. Variance homogeneity and normality were investigated by residual plots, histograms and Shapiro-Wilk's test and data were transformed when needed. Post hoc comparisons were made, with Tukey-Kramer adjustment of significance levels for the pairwise comparison, using unpaired t-test. Relationships between changes in blood and anthropometric measures during LED-1 (D 8À0 ), M-1 (D 12À0 ), LED-2 (D 16À0 ) and M-2 (D 20À0 ) were investigated by Pearson's correlations. Changes were tested for normality by ShapiroWilk's test and were reinvestigated by Spearman's correlation test if normality could not be reached.
To derive composite measures of outcome variables, factor analysis was carried out using the PROC FACTOR procedure in SAS with principal components analysis and orthogonal rotation (varimax option in SAS). Principal component analysis is a vector space transform that can detect the internal structure of the relationships between variables. The variables hs-CRP, IL-6, fibrinogen, haptoglobin, transferrin, leptin and adiponectin were included. Screen plot of the eigenvalues and a criterion of eigenvalues 41 were used to determine the number of principal components to retain.
Results
Changes in body weight and composition Body weight, waist circumference and FM decreased significantly during both weight loss periods and the weight Effect of body fat loss on inflammatory markers A Belza et al reduction was maintained during the following weight maintenance period (Table 1) .
Changes in blood pressure during weight reduction and maintenance Heart rate and systolic and diastolic blood pressure were significantly decreased after LED-1 compared to baseline (Table 1 ). There was no significant effect of the second weight loss on heart rate, or on systolic or diastolic blood pressure. Blood pressure was unchanged during the weight maintenance programs, M-1 and M-2.
Change in inflammatory markers or adipokines during weight reduction and maintenance The concentration of hs-CRP was not significantly changed by the 8-week weight loss period (LED-1) but it was significantly reduced by 35% after the subsequent 4-week weight loss (LED-2) (À1.1 (À2.5:0.2) (mean, 95% CI) mg l Fibrinogen and adiponectin were not changed by the weight loss programs (LED-1 and LED-2) (Figures 1c and d) and no significant changes were found at completion of the study.
The concentrations of haptoglobin, transferrin and leptin were significantly reduced after both LED-1 and LED-2 (Po0.001), but increased during the following weight maintenance periods. However, all assessed levels of leptin (Table 2) were significantly reduced compared to baseline, whereas the levels of haptoglobin and transferrin after M-1 and M-2 were not significantly different from baseline (Figures 1e and f) .
There was no effect of gender or age on the responsiveness of any of the measured pro-inflammatory markers and adipokines during the intervention periods.
Relationship between hs-CRP and other pro-inflammatory markers or adipokines Change between baseline level and LED-1 (D 8À0 ) correlated between hs-CRP, fibrinogen and haptoglobin (hs- The principal component analysis showed that hs-CRP, IL-6, fibrinogen and haptoglobin were closely related to the first principal component, with loadings between 0.63 and 0.81, whereas leptin and adiponectin were related to the second principal component, with loadings of 0.52 and 0.62, respectively. Loadings of transferrin were low for both the first (0.03) and second principal components (0.35) (Figure 2 ).
Effect of body weight, BMI and fat mass
There was an effect of body weight, BMI and FM on the responsiveness of all the assessed hs-CRP-levels to weight Abbreviations: BMI, body mass index; BW, body weight; DBP, diastolic blood pressure; FFM, fat free mass (assessed by bioimpedance); FM, fat mass (assessed by bioimpedance); HR, heart rate; LED-1, 8-week weight reduction; M-1, 4-week maintenance; LED-2, 4-week weight reduction; M-2, 4-week weight maintenance; SBP, systolic blood pressure. Data were analyzed using mixed model analysis of covariance. Post hoc comparisons were made between the periods, with TukeyKramer adjustment of significance levels for the pairwise comparison. Means sharing the superscript 'a' are significantly different from baseline level at Po0.05. The superscript letter 'b' indicates that the means are significantly different from LED-1 (8-week weight reduction), 'c' significantly different from M-1 (4-week weight maintenance).
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A Belza et al reduction and maintenance. The observed reduction in hs-CRP after LED-2 and M-2 was insignificant after adjustment. An effect of FM and BMI was observed on IL-6 and FM on fibrinogen, though this was not statistically significant for either measure. An effect of body weight, BMI and FM on transferrin levels was observed: the observed decrease after e: haptoglobin and f: transferrin) and body fat mass at baseline, and after 8-week weight reduction, 4-week weight maintenance, 4-week weight reduction, and 4-week weight maintenance, respectively in 33 obese subjects (16 males and 17 females). Data are given as mean ± s.e and were analysed using mixed model analysis of covariance. Significance level: *Po0.05, ***Po0.001 from baseline level. Effect of body fat loss on inflammatory markers A Belza et al both weight reductions was insignificant after adjustment for BMI and the significant reduction in transferrin after LED-2 disappeared after adjustment for body weight and FM. The significant changes in haptoglobin disappeared after adjustment for FM, whereas no effect of the covariates was observed for adiponectin. Except for transferrin no relationships were found between the pro-inflammatory markers/adipokines and anthropometric measures in changes between baseline and the other periods. Change in transferrin correlated in general to change in body weight, BMI, FM after LED-1 (D 8À0 ), LED-2 (D 16À0 ) and M-2(D 20À0 ), but only to BMI after M-1(D 12À0 ).
Changes in insulin, glucose and HOMA during weight reduction and maintenance Insulin, glucose and thereby also HOMA levels were significantly reduced after both weight loss programs, but increased significantly after the subsequent weight maintenance periods (Table 2 ). All assessed serum levels of insulin and HOMA were significantly decreased (Po0.0001) from baseline ( Table 2 ). The concentration of glucose after both weight maintenance periods was, however, insignificantly different from baseline ( Table 2) .
The changes from baseline in hs-CRP did not correlate to any of the glycemic markers, whereas change in IL-6 correlated to change in insulin and HOMA after M-1 (D 12À0 : À0. 43 Change in lipid level during weight reduction and maintenance The concentration of total cholesterol and LDL-cholesterol was significantly reduced after both weight loss programs but increased significantly after both weight maintenance programs. However, all assessed serum levels were significantly decreased compared with baseline (Po0.05) ( Table 2) .
HDL-cholesterol increased between LED-1 and M-1 (P ¼ 0.001). Otherwise, no difference in HDL level was observed from baseline throughout the intervention ( Table 2 ). The concentration of triglycerides was significantly reduced after 8, 12, 16 and 20 weeks of intervention compared with the baseline level (Po0.0001), but no significant difference was seen between levels of triglycerides after weight reduction and maintenance periods ( Table 2) .
The assessed changes from baseline in pro-inflammatory markers and adipokines were not in general associated with the assessed changes in blood lipids.
Discussion
In this study hs-CRP and IL-6 was not reduced by the negative energy balance induced by the first substantial weight loss (LED-1), whereas hs-CRP reduced significantly after the second smaller weight loss (LED-2). The reduction was kept during the last weight maintenance period. Additionally, the IL-6 concentration also decreased significantly after the second weight maintenance period (M-2), which could suggest that the reduction of body fat stores is responsible for the decrease in hs-CRP and IL-6. The same trend was seen in the concentration of fibrinogen. However, even though fibrinogen became numerically decreased after the second weight maintenance period, no significant difference was observed between initiation and completion of the study. By contrast, the plasma haptoglobin and transferrin decreased during both negative energy balance periods (LED-1 and LED-2), and tended to return to baseline levels after the subsequent maintenance period (M-1 and M-2), suggesting that these markers are affected by a negative energy balance, but not by the reduction in body weight per se. However, the loading plot from the principal component analysis of the pro-inflammatory markers showed a pattern of relation between hs-CRP, IL-6, fibrinogen and haptoglobin, whereas patterns of transferrin, leptin and adiponectin were less clear.
There is solid evidence to indicate that substantial weight reductions (20-40 kg (18-32%)) in morbid obese patients cause a marked decrease in hs-CRP, IL-6 and fibrinogen. 16, 28, 29, 35, 36 However, only hs-CRP and IL-6 were Figure 2 Loading plot of factor structure of the pro-inflammatory markers high-sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), fibrinogen, haptoglobin, transferrin and the adipokines leptin and adiponectin. Factor 1 was related to fibrinogen (0.81), CRP (0.63), haptoglobin (0.71), IL-6 (0.64) whereas adiponectin, leptin and transferrin were not. Factor 2 was related to leptin (0.62) and adiponectin (0.53), but not to the other markers. The factor analysis was carried out using the PROC FACTOR procedure with principal components analysis and orthogonal rotation.
Effect of body fat loss on inflammatory markers A Belza et al significantly reduced at completion of the present study, even though the reduction in body weight and fat after the first and second weight loss was considerable, 13% (13.7 kg) and 16% (16.6 kg), respectively. There is some evidence to suggest that a weight loss should exceed 10% of the initial body weight to reduce the level of inflammatory markers for long term improvement. 37 However, the present weight losses exceeded 10% without causing acute decrease in the pro-inflammatory markers. The level of obesity may therefore explain the missing acute reduction in IL-6, fibrinogen and partly hs-CRP, as the present participants were not morbidly obese and had no evidence of metabolic or systemic diseases. However, other studies with similar subject groups have observed significant acute reductions in hs-CRP, 15, [17] [18] [19] [38] [39] [40] IL-6 14, 15, 17, 39, [41] [42] [43] and fibrinogen 23, 30, [44] [45] [46] at smaller and similar weight losses (4-20 kg).
One explanation could be that the present study was underpowered to detect a significant change in the pro-inflammatory markers after weight reduction. On the other hand, other studies have observed no effect or an increase in pro-inflammatory markers after a rapid and significant weight loss. 37, 38, [47] [48] [49] [50] [51] These observations may, to some extent, explain why the smaller reductions in hs-CRP, IL-6 and fibrinogen after both periods with substantial body weight losses became more obvious when body weight was stabilized in the following maintenance period. An explanation for not finding clear evidence of an acute effect of weight loss may be that the positive effect of body fat reduction on hs-CPR, IL-6 and fibrinogen levels is counteracted by the negative energy balance, most likely due to an adverse effect on the liver of a high influx of portal-free fatty acids. The elevated influx of portal-free fatty acids in a state of a negative energy balance with mobilization of portal-free fatty acids from the visceral fat may affect the hepatocytes, and consequently promote the synthesis of cytokines and increase the level of acute phase reactants. Thus the cascade of action may mask the beneficial effect of body fat reduction. The duration and the rate of weight reduction may therefore be critical when assessing the beneficial effect of fat loss on low-grade inflammation. However, this hypothesis is not fully developed and cannot explain why the present findings diverge from those found in three similar 6 to 12-week study designs. 18, 38, 39 In a recent metaanalysis of 33 weight loss interventions, Selvin et al. 43 concluded that there was a strong association between declines in body weight and hs-CRP level, and that weight reduction was an effective non-pharmacological strategy for lowering plasma hs-CRP. This study does not support this finding, as no correlation was found between reduction in hs-CRP and body weight or FM. However, this is possibly due to this study being simply underpowered to detect a correlation. Like hs-CRP, haptoglobin is a positive acute phase protein as the plasma concentration will increase in inflammation. Transferrin is an acute phase protein that normally will decrease in inflammation. 12 We therefore expected transferrin to increase and haptoglobin to decrease as a response to weight loss. However, haptoglobin and transferrin both decreased during the negative energy balance periods, and tended to return to baseline levels after the subsequent maintenance period. These results could suggest that the markers are more affected by a negative energy balance and less by the reduction in body weight per se. The present fluctuations in haptoglobin and transferrin are supported by previous findings of the two markers responding to the energy flux. 27, 52, 53 In one study it was observed that total fasting could reduce haptoglobin and transferrin levels. After the subjects were given an 800-kcal diet, though the subjects were still in negative energy balance, transferrin increased again but haptoglobin began to increase during the last part of the fasting period and increased further after the calorie intake. 27 Diet composition was not identical during the weight loss and maintenance periods and was not recorded, though both diet regimes were high in protein (LED: 38 E%; and weight maintenance: minimum 60 g protein per day 31 ) and low in fat and simple carbohydrates. However, there is little evidence to suggest that dietary macronutrient composition affects pro-inflammatory markers. 38, 39, [52] [53] [54] [55] The adipokines adiponectin and leptin have previously been connected with pro-inflammatory markers. A reduction in FM has been shown to induce a decline in leptin concentration 28, 35, 40, 41 and a rise in adiponectin concentration. 14, 15, 29, 40 However, the present study failed to provide the expected increase in adiponectin as a response to the fat loss possibly due to the study being simply underpowered. We found only a negative correlation between the change in hs-CRP and adiponectin at completion of the study. Only one of the above studies found a relationship between change in IL-6 and adiponectin as a result of a substantial weight loss (20 kg after 8-week LED). 14 The lack of a correlation between the change in adipokines and/or acute phase proteins may be explained by the extent of dependence of the FM reduction on the individual protein, but probably also by the skewed distribution of hs-CRP and IL-6 plasma levels. In addition, the observed fluctuations in leptin could support that leptin may be partly influenced by the energy flux as in the case of haptoglobin and transferrin. Although the mechanisms associating the metabolic syndrome, adiposity and pro-inflammatory markers remain elusive, several studies have shown that an FM reduction induces a decline in pro-inflammatory markers and markers of IRS such as plasma glucose, insulin and HOMA. 10, 11, [14] [15] [16] [17] 19, 28, 29, 42 The present concentration of glucose, insulin and HOMA decreased after weight losses but tended to rise towards baseline level in the subsequent weight maintenance periods. No relationship was observed between the changes in hs-CRP and the glycemic markers, whereas the change in IL-6 related to insulin and HOMA after the first weight loss but not the second. The association between changes in IL-6, insulin and HOMA after weight reduction have been found in some studies, [15] [16] [17] 42 whereas
Effect of body fat loss on inflammatory markers A Belza et al other studies have not found any relationships. 18, 36, 38, 40 The general absence of correlation between change in hs-CRP and IL-6 and glycemic risk markers of IRS and CVD may be explained by an indirect relationship between the quantity of FM mass and the influence of energy balance, which seems to have a partial influence on concentration levels.
In conclusion, the results suggest that although lipid and glucose metabolism are markedly influenced by both energy balance and changes in body fat, the reduction in hs-CRP and IL-6 do not seem to be achieved by effects brought about by negative energy balance, but are a result of the reduced FM. Thus hs-CRP and IL-6 appear to be applicable indices of health status in relation to obesity and risk reduction of IRS and CVD after weight loss. In addition, the results signify that maintenance of the reduced body weight may have beneficial consequences on pro-inflammatory level and health in obese individuals.
